Sarepta Therapeutics(CH:AB3A)
CH:AB3A
Sarepta Therapeutics earnings date
Sarepta Therapeutics (AB3A) Q2 2022 Earnings Report
0 Followers
CH:AB3A Q2 2022 EPS Results
- Actual EPS
- -CHF 2.21
- Consensus EPS
- -CHF 0.93
- Beat/Miss
- Missed by -CHF 1.29
- One Year Ago EPS
- -CHF 0.85
CH:AB3A Q2 2022 Revenue Results
- Actual Revenue
- CHF 195.03M
- Expected Revenue
- CHF 184.44M
- Beat/Miss
- Beat by +CHF 10.59M
- YoY Revenue Growth
- +42.29%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/02/2022
- Time
- After Close
- Conference Call
- Tuesday, August 2, 2022
CH:AB3A Upcoming Earnings
Sarepta Therapeutics's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:AB3A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.30- | -3.28 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 0.07-0.23 | -1.5 | 85.00% (+1.28) | |
| Aug 05, 2026 | 2026 (Q2) | 0.18-0.04 | 1.58 | -102.65% (-1.62) | |
| May 06, 2026 | 2026 (Q1) | 0.822.41 | -3.84 | 162.61% (+6.25) | |
| Feb 25, 2026 | 2025 (Q4) | -1.00-3.28 | 1.25 | -362.00% (-4.54) | |
| Nov 03, 2025 | 2025 (Q3) | -0.61-1.50 | 0.28 | -629.41% (-1.79) | |
| Aug 06, 2025 | 2025 (Q2) | 0.691.58 | 0.06 | 2600.00% (+1.52) | |
| May 06, 2025 | 2025 (Q1) | -2.68-3.84 | 0.31 | -1343.24% (-4.15) | |
| Feb 26, 2025 | 2024 (Q4) | 1.571.25 | 0.39 | 219.15% (+0.86) | |
| Nov 06, 2024 | 2024 (Q3) | -0.060.28 | -0.38 | 173.91% (+0.67) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

